Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Did Avalanche’s New NYSE Deal Just Make Solana and XRP Irrelevant?

Key PointsAvalanche scored a symbolic win by agreeing to set up an on-chain exchasnge for the NYSE.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at nasdaq.com →

More in Finance & Markets

CME vs. Upstart: Which Financial Stock Is a Better Buy for 2027?

CME's roughly $4 billion profit and near-zero leverage stand in contrast to Upstart's 64% revenue surge, but the lending specialist's leverage and negative free cash flow tell a different story.

  • CME Group reported $6.5 billion revenue in 2025, up 6.4% YoY
  • Upstart reported $1 billion revenue in 2025, up 64% YoY
  • CME has low debt-to-equity ratio of 0.1, Upstart's is 2.3

More from Wednesday 18 November →